Chiara Parazzoli

Chiara Parazzoli

Auto-generated profile, based on publicly available information

Chiara Parazzoli

Department of Medical Biotechnology and Translational Medicine, University of Milan , 20122 Milan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Best Practice & Research Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
CACarmen Aresta
Carmen Aresta
VFVittoria Favero
Vittoria Favero
Valentina MorelliValentina Morelli
Valentina Morelli
LGLuca Giovanelli
Luca Giovanelli
CPChiara Parazzoli
Chiara Parazzoli
Iacopo ChiodiniIacopo Chiodini
Iacopo Chiodini

Verified
Journal Article
Open access
PDF file
VFVittoria Favero
Vittoria Favero
ACArianna Cremaschi
Arianna Cremaschi
CPChiara Parazzoli
Chiara Parazzoli
ALBERTO FALCHETTIALBERTO FALCHETTI
ALBERTO FALCHETTI
Agostino GaudioAgostino Gaudio
Agostino Gaudio
Iacopo ChiodiniIacopo Chiodini
Iacopo Chiodini
Mild hypercortisolism is defined as biochemical evidence of abnormal cortisol secretion without the classical detectable manifestations of overt Cushing’s syndrome and, above all, lacking catabolic characteristics such as central muscle weakness, adipose tissue redistribution, skin fragility and unusual infections. Mild hypercortisolism is frequently discovered in patients with adrenal incidentalomas, with a prevalence ranging between 5 and 50%. This high variability is mainly due to the different criteria used for defining this condition. This subtle cortisol excess has also been described in patients with incidentally discovered pituitary tumors with an estimated prevalence of 5%. To date, the mechanisms responsible for the pathogenesis of mild hypercortisolism of pituitary origin are still not well clarified. At variance, recent advances have been made in understanding the genetic background of bilateral and unilateral adrenal adenomas causing mild hypercortisolism. Some recent data suggest that the clinical effects of glucocorticoid (GC) exposure on peripheral tissues are determined not only by the amount of the adrenal GC production but also by the peripheral GC metabolism and by the GC sensitivity. Indeed, in subjects with normal cortisol secretion, the combined estimate of cortisol secretion, cortisone-to-cortisol peripheral activation by the 11 beta-hydroxysteroid dehydrogenase enzyme and GC receptor sensitizing variants have been suggested to be associated with the presence of hypertension, diabetes and bone fragility, which are three well-known consequences of hypercortisolism. This review focuses on the pathophysiologic mechanism underlying both the different sources of mild hypercortisolism and their clinical consequences (bone fragility, arterial hypertension, subclinical atherosclerosis, cardiovascular remodeling, dyslipidemia, glucose metabolism impairment, visceral adiposity, infections, muscle damage, mood disorders and coagulation).

24 April 2024 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
CPChiara Parazzoli
Chiara Parazzoli
APAlessandro Prete
Alessandro Prete
VFVittoria Favero
Vittoria Favero
CACarmen Aresta
Carmen Aresta
VPvalentina pucino
valentina pucino
CRCristina L Ronchi
Cristina L Ronchi
Background Pheochromocytoma is associated with systemic inflammation but the underlying mechanisms are unclear. Therefore, we investigated the relationship between plasma metanephrine levels and hematological parameters—as a surrogate of inflammation—in patients with pheochromocytoma and the influence of preoperative α-blockade treatment. Design and Methods We retrospectively studied 68 patients with pheochromocytoma who underwent adrenalectomy (median age, 53 years; 64.7% females) and 2 control groups matched for age, sex, and body mass index: 68 patients with nonfunctioning adrenocortical tumors and 53 with essential hypertension. The complete blood count and several inflammation-based scores (neutrophil-to-lymphocyte ratio [NLR], platelet-to-lymphocyte ratio [PLR], lymphocyte-to-monocyte ratio [LMR], systemic-immune-inflammation index [SII], prognostic-nutrition index) were assessed in all patients and, in a subset of pheochromocytomas, after adrenalectomy (n = 26) and before and after preoperative α-blockade treatment (n = 29). Results A higher inflammatory state, as indicated by both complete blood count and inflammation-based scores, was observed in patients with pheochromocytoma compared with nonfunctioning adrenocortical tumors and essential hypertension. Plasma metanephrine levels showed a positive correlation with NLR (r = 0.4631), PLR (r = 0.3174), and SII (r = 0.3709) and a negative correlation with LMR (r = 0.4368) and prognostic-nutrition index (r = 0.3741), even after adjustment for age, sex, ethnicity, body mass index, and tumor size (except for PLR). After adrenalectomy, we observed a reduction in NLR (P = .001), PLR (P = .003), and SII (P = .004) and a concomitant increase in LMR (P = .0002). Similarly, α-blockade treatment led to a reduction in NLR (P = .007) and SII (P = .03). Conclusion Inflammation-based scores in patients with pheochromocytoma showed pro-inflammatory changes that correlated with plasma metanephrine levels and are ameliorated by adrenalectomy and α-blockade.

10 September 2026 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
CPChiara Parazzoli
Chiara Parazzoli
ADAndrea Delbarba
Andrea Delbarba
ASAlberto Scala
Alberto Scala
ABAlessandro Brunetti
Alessandro Brunetti
RCRoberto Castello
Roberto Castello
SBStefania Bonadonna
Stefania Bonadonna
Purpose: Transgender and gender diverse (TGD) individuals have various medical needs, but limited healthcare professionals’ expertise remains a major barrier to care. Data on the preparedness of Italian endocrinologists to provide TGD care are scarce. This study assessed Italian endocrinologists’ knowledge, clinical practice, and educational needs in gender-affirming care. Methods: A nationwide survey developed by the Association of Medical Endocrinologists (AME), with support from the Italian Society for Gender, Identity and Health, was distributed to all AME members in 2023. Multivariable logistic regression identified factors associated with knowledge, self-reported ability to manage gender-affirming hormone therapy (GAHT) and interest in further education. Results: Overall, 703 endocrinologists completed the survey. Only 8.4% reported frequent clinical involvement with TGD patients, and fewer than 15% considered themselves able to initiate and monitor GAHT. Previous education in gender-affirming care was the strongest determinant of knowledge (OR 14.3) and self-reported ability to manage GAHT (OR 4.4). Younger age was associated with greater knowledge but not with perceived clinical competence. Nevertheless, 90.4% expressed interest in further education. Conclusion: Italian endocrinologists show substantial gaps in preparedness for transgender care. Structured education in gender-affirming care is strongly associated with greater knowledge and self-reported ability to manage GAHT, supporting the implementation of educational programs to improve access to competent endocrine care for TGD individuals.